WellSpan THRIVE Cancer Quality of Life Program
Official title: WellSpan Study of Tracking Health and Resilience to Improve the Vitality of Individuals Experiencing Cancer [WellSpan-THRIVE]
Run by WellSpan Health · NCT07433660 · Data updated 2026-11-12
This program will try a patient-focused quality-of-life survey to learn how cancer and its treatments affect adults newly diagnosed with cancer.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | WellSpan Health Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 5 sites (Chambersburg, Pennsylvania and 4 other locations) |
| Status | Recruiting |
| Started | February 2026 |
| Main results expected | February 2031 |
| Study ends | December 2031 |
| Registry record updated | March 2, 2026 |
| Trial ID | NCT07433660 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 and older with a new primary cancer diagnosis within the past six months who can provide informed consent and complete questionnaires are ideal candidates.
✕Probably not a fit
Patients with primary non-melanoma skin cancer, primary brain or hematologic malignancies, severe cognitive impairment, or a life expectancy under 90 days are unlikely to benefit from participating.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational registry will develop and implement a patient-centered quality-of-life (QOL) survey tailored for people with cancer, using direct patient input to capture what matters most in daily life. Eligible participants are adults with a new primary cancer diagnosis within the past six months, excluding non-melanoma skin cancers, primary brain tumors or metastases, and hematologic malignancies. Participants will complete standardized and patient-informed questionnaires at WellSpan oncology sites to document symptoms, function, and social and emotional impacts over time. Collected data will be used to better identify needs and inform supportive care for patients and families.
Why it matters
Potential benefit: If successful, the survey could help clinicians and care teams identify unmet needs and target supportive services to improve patients' daily functioning and well-being.
How similar studies have gone: Patient-reported outcome instruments like the EORTC QLQ and FACT have been used successfully in cancer populations, so this work builds on established methods though the specific patient-centered survey may be novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years and above * Primary cancer diagnosis (newly diagnosed within the past 6 months) * Able to sign informed consent. Exclusion Criteria: * Patients with age\<18 years, * Patients with primary non-melanoma skin, neurological malignancies (Brain or brain metastases), and primary hematological malignancies. * Patients with severe cognitive impairment, unable to sign informed consent or unable to complete quality of life questionnaire. * Patients with life expectancy of \<90 days, in the opinion of treating investigator.
Where it's running
-
WellSpan Medical Oncology & Hematology
Chambersburg, Pennsylvania, United States Recruiting -
WellSpan Ephrata Cancer Center
Ephrata, Pennsylvania, United States Recruiting -
WellSpan Adams Cancer Center
Gettysburg, Pennsylvania, United States Recruiting -
WellSpan Sechler Family Cancer Center
Lebanon, Pennsylvania, United States Recruiting -
WellSpan York Cancer Center
York, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Navesh Sharma, DO, PhD, FACRO — WellSpan Health
- Study coordinator: Joan K Moore, MSN, RN, OCN, CCRP
- Email: jmoore@wellspan.org
- Phone: 717-741-8124
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Does the 1939 Cancer Act still work in the internet and social media age?
This survey asks people treated for cancer and health professionals in England and Wales about online and social media cancer information to see if the 1939 Cancer Act needs updating.
-
SBRT-LATTICE-PATHY for Large Tumors
This trial tests a targeted radiotherapy approach (SBRT-LATTICE-PATHY) to treat large, intractable solid tumors in adults.
-
Live online group exercise for cancer survivors
This trial will test whether live online group exercise helps people who have finished primary cancer treatment become more active, fitter, and less lonely compared with prerecorded exercise videos.
-
Steroid-Sparing Plan with Olanzapine and Palonosetron to Prevent Nausea in High-Dose Cisplatin
This phase II trial tests a steroid-sparing regimen using olanzapine and palonosetron to prevent chemotherapy-induced nausea and vomiting in patients getting high-dose cisplatin.
-
Dietary Supplements and Cancer Patients: Use, Tolerance, and Interactions
This study looks at how many cancer patients take dietary supplements, how they tolerate them, and whether these supplements interact with cancer treatments.
-
Glutamine-based PET/CT to detect cancer using 18F-FGln in patients with suspected or known tumors
This study tests whether 18F-FGln PET/CT can help identify and stage various cancers in patients with suspected or existing tumors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.